Article Text

PDF
Neuroendocrine tumours—challenges in the diagnosis and classification of pulmonary neuroendocrine tumours
  1. M A den Bakker1,2,
  2. F B J M Thunnissen3
  1. 1Department of Pathology, Maasstad Hospital, Rotterdam, The Netherlands
  2. 2Department of Pathology Erasmus MC, Rotterdam, The Netherlands
  3. 3Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
  1. Correspondence to Dr M A den Bakker, Department of Pathology, Maasstad Ziekenhuis, PO Box 3100, Rotterdam 3007 AC, The Netherlands; bakkerma{at}maasstadziekenhuis.nl, m.denbakker{at}erasmusmc.nl

Abstract

Pulmonary neuroendocrine (NE) proliferations are a diverse group of disorders which share distinct cytological, architectural and biosynthetic features. Tumours composed of NE cells are dispersed among different tumour categories in the WHO classification of tumours and as such do not conform to a singular group with regards to treatment and prognosis. This is reflected by the highly variable behaviour of NE proliferations, ranging from asymptomatic, for instance in diffuse idiopathic pulmonary NE cell hyperplasia and tumourlets, to highly malignant cancers such as small cell lung cancer and large cell NE carcinoma. In this review NE proliferations are described as distinct entities ranging from low grade lesions to high grade cancers. The differential diagnoses are considered with each of the entries. Finally, mention is made of tumours which may show some NE features.

  • Neuroendocrine
  • LUNG
  • HISTOPATHOLOGY

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.